Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Drug Discovery Today

• Publication date

  2009-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.drudis.2009.07.010PMID 19647803
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy.

  2009cited by this paper
• Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.

  2009cited by this paper
• Inhibiting efflux with novel non-ionic surfactants: Rational design based on vitamin E TPGS.

  2009cited by this paper
• Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies.

  2009cited by this paper
• Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drug.

  2009cited by this paper
• Effects of polyoxyethylene (40) stearate on the activity of P-glycoprotein and cytochrome P450.

  2009cited by this paper
• Reversal of multidrug resistance by methoxypolyethylene glycol-block-polycaprolactone diblock copolymers through the inhibition of P-glycoprotein function.

  2009cited by this paper
• Nanoparticles for drug delivery in cancer treatment.

  2008cited by this paper
• The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.

  2008cited by this paper
• Enhanced oral bioavailability of paclitaxel by D-alpha-tocopheryl polyethylene glycol 400 succinate in mice.

  2008cited by this paper
• Polymeric micelles in oral chemotherapy.

  2008cited by this paper
• Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers.

  2008cited by this paper
• Development of chitosan-SLN microparticles for chemotherapy: in vitro approach through efflux-transporter modulation.

  2008cited by this paper
• Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats.

  2007cited by this paper
• Paclitaxel-2′-Ethylcarbonate Prodrug Can Circumvent P-glycoprotein-mediated Cellular Efflux to Increase Drug Cytotoxicity

  2007cited by this paper
• Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells.

  2007cited by this paper
• Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux.

  2007cited by this paper
• Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.

  2007cited by this paper
• Natural and Synthetic Polymers as Inhibitors of Drug Efflux Pumps

  2007cited by this paper
• Impact of intraperitoneal, sustained delivery of paclitaxel on the expression of P-glycoprotein in ovarian tumors.

  2007cited by this paper
• Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.

  2007cited by this paper
• The effects of pharmaceutical excipients on drug disposition.

  2007cited by this paper
• In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan.

  2006cited by this paper
• Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.

  2006cited by this paper
• In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein.

  2006cited by this paper
• Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux.

  2006cited by this paper
• Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.

  2006cited by this paper
• The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.

  2006cited by this paper
• Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition.

  2006cited by this paper
• Self-assembled nanoparticles of poly(lactide)--Vitamin E TPGS copolymers for oral chemotherapy.

  2006cited by this paper
• Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers.

  2006cited by this paper
• Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization.

  2006cited by this paper
• Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies.

  2006cited by this paper
• Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine.

  2006cited by this paper
• In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors.

  2006cited by this paper
• Polymeric efflux pump inhibitors in oral drug delivery

  2006cited by this paper
• Polyplex Nanogel formulations for drug delivery of cytotoxic nucleoside analogs.

  2005cited by this paper
• Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo.

  2005cited by this paper
• Enhanced paclitaxel bioavailability after oral administration of pegylated paclitaxel prodrug for oral delivery in rats.

  2004cited by this paper
• Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer

  2004cited by this paper
• Enhanced Oral Absorption of Paclitaxel in a Novel Self-Microemulsifying Drug Delivery System with or Without Concomitant Use of P-Glycoprotein Inhibitors

  2004cited by this paper
• Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes.

  2004cited by this paper
• Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers.

  2004cited by this paper
• The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability.

  2004cited by this paper
• Prodrug chemotherapeutics bypass p-glycoprotein resistance and kill tumors in vivo with high efficacy and target-dependent selectivity

  2004cited by this paper
• Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo.

  2004cited by this paper
• Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines.

  2003cited by this paper
• Effects of polyether-modified poly(acrylic acid) microgels on doxorubicin transport in human intestinal epithelial Caco-2 cell layers.

  2003cited by this paper
• Liposome-based approaches to overcome anticancer drug resistance.

  2003cited by this paper
• Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel.

  2003cited by this paper
• Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers.

  2002cited by this paper
• Recent progress in drug delivery systems for anticancer agents

  2002cited by this paper
• HPMA-hydrogels containing cytostatic drugs. Kinetics of the drug release and in vivo efficacy.

  2002cited by this paper
• A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro.

  2002cited by this paper
• Triton‐X‐100‐modified polymer and microspheres for reversal of multidrug resistance

  2001cited by this paper
• Effect of PSC 833 liposomes and Intralipid on the transport of epirubicin in Caco-2 cells and rat intestines.

  2001cited by this paper
• Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs.

  2000cited by this paper
• Modulation of daunorubicin toxicity by liposomal encapsulation and use of specific inhibitors in vitro.

  2000cited by this paper
• Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials

  1999cited by this paper
• A possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrier.

  1999cited by this paper
• Poly(ethylene glycol)–polyethyleneimine NanoGel™ particles: novel drug delivery systems for antisense oligonucleotides

  1999cited by this paper
• Effects of Pluronic Block Copolymers on Drug Absorption in Caco-2 Cell Monolayers

  1998cited by this paper
• Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance.

  1993cited by this paper
• Reversal of multidrug resistance by surfactants.

  1992cited by this paper
• Potentiation of drug effect by Tween 80 in Chinese hamster cells resistant to actinomycin D and daunomycin.

  1972cited by this paper

• Surfactant-Enabled Nanocarriers in Breast Cancer Therapy: Targeted Delivery and Multidrug Resistance Reversal

  2025cites this paper
• Oral Bioavailability Enhancement of Anti-Cancer Drugs Through Lipid Polymer Hybrid Nanoparticles

  2025cites this paper
• Nanotechnology-Driven Colorectal Cancer Treatment: Coencapsulation of Irinotecan and Cyclosporine A in SNEDDS for Superior Outcomes.

  2025cites this paper
• Exploring the potential of P-glycoprotein inhibitors in the targeted delivery of anti-cancer drugs: A comprehensive review.

  2024cites this paper
• Coconut-sourced MCT oil: its potential health benefits beyond traditional coconut oil

  2024cites this paper
• Vitamin E and A increase the passing of the P-gp substrate ivermectin into the brain in mice.

  2023cites this paper
• Insight into RNA-based therapies for ovarian cancer.

  2023cites this paper
• Formulation, characterization, pharmacokinetics and antioxidant activity of Phloretin oral granules.

  2023cites this paper
• Implication of metabolomics and transporter modulation based strategies to minimize multidrug resistance and enhance site-specific bioavailability: a needful consideration toward modern anticancer drug discovery

  2022cites this paper
• Cubosomes for Enhancing Intestinal Absorption of Fexofenadine Hydrochloride: In situ and in vivo Investigation

  2022cites this paper
• Microemulsion –A Multidimensional Formulation

  2022cites this paper
• Designing and development of omega-3 fatty acid based self-nanoemulsifying drug delivery system (SNEDDS) of docetaxel with enhanced biopharmaceutical attributes for management of breast cancer

  2022cites this paper
• Non-ionic Surfactants as a P-Glycoprotein(P-gp) Efflux Inhibitor for Optimal Drug Delivery—A Concise Outlook

  2022cites this paper
• Evaluation of the effect of isobutyl paraben and 2-ethyl hexyl paraben on p-glycoprotein functional expression in rats: a pharmacokinetic study.

  2022cites this paper
• Self-emulsifying drug delivery system for oral anticancer therapy: constraints and recent development.

  2022cites this paper
• Multifunctional nanoplatforms co-delivering combinatorial dual-drug for eliminating cancer multidrug resistance

  2021cites this paper
• Pharmaceutical Formulations with P-Glycoprotein Inhibitory Effect as Promising Approaches for Enhancing Oral Drug Absorption and Bioavailability

  2021cites this paper
• A comprehensive insight on self emulsifying drug delivery systems.

  2021cites this paper
• Recent Advances in the Local Drug Delivery Systems for Improvement of Anticancer Therapy.

  2021cites this paper
• Improved Dissolution Rate and Intestinal Absorption of Fexofenadine Hydrochloride by the Preparation of Solid Dispersions: In Vitro and In Situ Evaluation

  2021cites this paper
• Overcoming vincristine resistance in cancer: Computational design and discovery of piperine‐inspired P‐glycoprotein inhibitors

  2020cites this paper
• Development of tamoxifen-loaded surface-modified nanostructured lipid carrier using experimental design: in vitro and ex vivo characterisation.

  2020cites this paper
• Supersaturated LFCS type III self-emulsifying delivery systems of sorafenib tosylate with improved biopharmaceutical performance: QbD-enabled development and evaluation

  2020cites this paper
• Nanomedicine solutions to intricate physiological-pathological barriers and cellular factors of tumor multidrug resistance.

  2020cites this paper
• Novel β-1,3-d-glucan porous microcapsule enveloped folate-functionalized liposomes as a Trojan horse for facilitated oral tumor-targeted co-delivery of chemotherapeutic drugs and quantum dots.

  2020cites this paper
• Self-microemulsifying drug-delivery system: ongoing challenges and future ahead

  2020cites this paper
• Self-Generating nano-emulsification techniques for alternatively-routed, bioavailability enhanced delivery, especially for anti-cancers, anti-diabetics, and miscellaneous drugs of natural, and synthetic origins

  2020cites this paper
• Self-emulsifying Drug Delivery System Improve Oral Bioavailability: Role of Excipients and Physico-chemical Characterization.

  2020cites this paper
• Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.

  2019cites this paper
• Various Challenges and Opportunities in Oral Delivery of Anticancer Drugs

  2019cites this paper
• Multifunctional Mesoporous Silica Nanoparticle for Simultaneous Doxorubicin Delivery and Bioimaging

  2019cites this paper
• Carrier-Free Supramolecular Hydrogel Composed of Dual Drugs for Conquering Drug Resistance.

  2019cites this paper
• Intestinal transport mechanism and in vivo anticancer efficacy of a solid oral formulation incorporating an ion-pairing complex of pemetrexed with deoxycholic acid derivative

  2019cites this paper
• A self-nanoemulsifying drug delivery system for enhancing the oral bioavailability of candesartan cilexetil: Ex-vivo and in-vivo evaluation.

  2019cites this paper
• Shedding light on interaction of so called inactive ingredients (excipients) with permeability-glycoprotein

  2019cites this paper
• Evaluating Ternary Metal Oxide (TMO) core-shell nanocomposites for the rapid determination of the anti-neoplastic drug Chlorambucil (Leukeran™) by electrochemical approaches.

  2019cites this paper
• Harmine-loaded galactosylated pluronic F68-gelucire 44/14 mixed micelles for liver targeting

  2019cites this paper
• Advance In-silico based Predictive In-Vivo Profiling of Novel Potent β-Glucuronidase Inhibitors.

  2019cites this paper
• Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR.

  2018cites this paper
• Role of self-emulsifying drug delivery systems in optimizing the oral delivery of hydrophilic macromolecules and reducing interindividual variability.

  2018cites this paper
• P-glycoprotein-targeted photodynamic therapy boosts cancer nanomedicine by priming tumor microenvironment

  2018cites this paper
• Methotrexate-Loaded Nanomixed Micelles: Formulation, Characterization, Bioavailability, Safety, and In Vitro Anticancer Study

  2018cites this paper
• Improvement of intestinal transport, absorption and anti‐diabetic efficacy of berberine by using Gelucire44/14: In vitro, in situ and in vivo studies

  2018cites this paper
• Surface colonized silver nano particles over chitosan poly-electrolyte micro-spheres and their multi-functional behavior

  2018cites this paper
• Self-nanoemulsifying Drug Delivery System of Mebendazole for Treatment of Lymphatic Filariasis

  2018influential citation
• Polyphenols and Their Interactions With Other Dietary Compounds: Implications for Human Health.

  2018cites this paper
• Engineering Multifunctional Nanomedicine Platforms for Drug Delivery and Imaging

  2018cites this paper
• Different structures of berberine and five other protoberberine alkaloids that affect P-glycoprotein-mediated efflux capacity

  2018cites this paper
• Dendrimer‐like mesoporous silica nanospheres with suitable surface functionality to combat the multidrug resistance

  2018cites this paper
• Thiol redox-sensitive cationic polymers for dual delivery of drug and gene.

  2018cites this paper
• Self-emulsifying drug-delivery systems modulate P-glycoprotein activity: role of excipients and formulation aspects.

  2018cites this paper
• Hyaluronated imatinib liposomes with hybrid approach to target CD44 and P-gp overexpressing MDR cancer: an in-vitro, in-vivo and mechanistic investigation

  2018cites this paper
• Enhanced Biopharmaceutical Performance of Rivaroxaban through Polymeric Amorphous Solid Dispersion.

  2018cites this paper
• Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect

  2018cites this paper
• RETRACTED ARTICLE: Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations

  2018cites this paper
• Co-loading of photothermal agents and anticancer drugs into porous silicon nanoparticles with enhanced chemo-photothermal therapeutic efficacy to kill multidrug-resistant cancer cells.

  2018cites this paper
• Effect of Self-Microemulsifying Lipid Formulations on the Dissolution and Compaction Profiles of Tablets Containing Theophylline; a BCS Class I Compound -

  2018influential citation
• Active intestinal drug absorption and the solubility-permeability interplay.

  2018cites this paper
• Selection and optimization of nano‐formulation of P‐glycoprotein inhibitor for reversal of doxorubicin resistance in COLO205 cells

  2017cites this paper
• MDR in cancer: Addressing the underlying cellular alterations with the use of nanocarriers.

  2017cites this paper
• Preparation and Characterization of Mucoadhesive Nanoparticles for Enhancing Cellular Uptake of Coenzyme Q10.

  2017cites this paper
• Recent progress in drug delivery of pluronic P123: pharmaceutical perspectives

  2017cites this paper
• In vitro assessment of the roles of drug transporters in the disposition and drug–drug interaction potential of olaparib

  2017cites this paper
• In-situ single pass intestinal permeability and pharmacokinetic study of developed Lumefantrine loaded solid lipid nanoparticles.

  2017influential citation
• Vitamin E TPGS based liposomal delivery of doxorubicin in osteosarcoma cancer cells

  2017cites this paper
• Therapeutic supermolecular micelles of vitamin E succinate-grafted ε-polylysine as potential carriers for curcumin: Enhancing tumour penetration and improving therapeutic effect on glioma.

  2017cites this paper
• Improving Tumor Specificity and Anticancer Activity of Dasatinib by Dual-Targeted Polymeric Micelles.

  2017cites this paper
• Development of Self-Microemulsifying Drug Delivery System (SMEDDS) for Poorly Water Soluble Anticancerous Drug

  2017cites this paper
• Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity

  2017cites this paper
• Investigation of Different Formulation Approaches to Enhance Oral Bioavailability of Paromomycin

  2017cites this paper
• Preparation and evaluation of self-microemulsions for improved bioavailability of ginsenoside-Rh1 and Rh2

  2017cites this paper
• Reversal of paclitaxel resistance in human ovarian cancer cells with redox-responsive micelles consisting of α-tocopheryl succinate-based polyphosphoester copolymers

  2017cites this paper
• Investigation of in vitro absorption, distribution, metabolism, and excretion and in vivo pharmacokinetics of paromomycin: Influence on oral bioavailability

  2017cites this paper
• Research progress on berberine with a special focus on its oral bioavailability.

  2016cites this paper
• Natural polyphenols: Influence on membrane transporters

  2016cites this paper
• The Ameliorated Pharmacokinetics of VP-16 in Wistar Rats: A Possible Role of P-Glycoprotein Inhibition by Pharmaceutical Excipients

  2016cites this paper
• Inhibition of MDR 1 in Mammary Cell Carcinoma Reverses Multidrug Resistance by SOCS 1

  2016cites this paper
• DESIGN AND DEVELOPMENT OF SELF-EMULSIFYING DRUG DELIVERY SYSTEMS NOVEL CARDIOACTIVE N-ACYLHYDRAZONE COMPOUND

  2016cites this paper
• Synergistic effects of A-B-C-type amphiphilic copolymer on reversal of drug resistance in MCF-7/ADR breast carcinoma

  2016cites this paper
• Colloidal carriers for extended absorption window of furosemide

  2016cites this paper
• Quantitative and Mechanistic Assessment of Model Lipophilic Drugs in Micellar Solutions in the Transport Kinetics Across MDR1-MDCK Cell Monolayers.

  2016cites this paper
• MMP2-Sensitive PEG-Lipid Copolymers: A New Type of Tumor-Targeted P-Glycoprotein Inhibitor.

  2016cites this paper
• Preparation of pH and redox dual-sensitive core crosslinked micelles for overcoming drug resistance of DOX

  2016cites this paper
• Intestinal P-glycoprotein: pharmacokinetic implications and approaches for enhancement of oral bioavailability of its substrates

  2016cites this paper
• How to design the surface of peptide-loaded nanoparticles for efficient oral bioavailability?

  2016cites this paper
• Liposomal systems as viable drug delivery technology for skin cancer sites with an outlook on lipid-based delivery vehicles and diagnostic imaging inputs for skin conditions'.

  2016cites this paper
• P-gp Inhibition-Based Strategies for Modulating Pharmacokinetics of Anticancer Drugs: An Update.

  2016cites this paper
• Hyaluronan/Hyaladherins - a Promising Axis for Targeted Drug Delivery in Cancer.

  2016cites this paper
• Supercritical fluid precipitation of ketoprofen in novel structured lipid carriers for enhanced mucosal delivery--a comparison with solid lipid particles.

  2015cites this paper
• Role of Components in the Formation of Self-microemulsifying Drug Delivery Systems

  2015cites this paper
• pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells

  2015cites this paper
• Liquid Chromatographic Method for Irinotecan Estimation: Screening of P-gp Modulators

  2015cites this paper
• Nanoscale drug delivery for taxanes based on the mechanism of multidrug resistance of cancer.

  2015cites this paper
• A folate modified pH sensitive targeted polymeric micelle alleviated systemic toxicity of doxorubicin (DOX) in multi-drug resistant tumor bearing mice.

  2015cites this paper
• Sirolimus‐loaded polymeric micelles with honokiol for oral delivery

  2015cites this paper
• Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy

  2015cites this paper
• Hyaluronan coated liposomes as the intravenous platform for delivery of imatinib mesylate in MDR colon cancer.

  2015cites this paper
• Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells.

  2015cites this paper
• A review of polymers as multifunctional excipients in drug dosage form technology

  2015influential citation
• Redox-Responsive Polyphosphoester-Based Micellar Nanomedicines for Overriding Chemoresistance in Breast Cancer Cells.

  2015cites this paper